Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 17;67(9):455-462.
doi: 10.17221/127/2021-VETMED. eCollection 2022 Jun.

Cannabidiol and the possibilities of its use in veterinary medicine of dogs and horses: A brief review

Leos Landa  1   2 , Vaclav Trojan  2 , Regina Demlova  1   3 , Jan Jurica  1   3 , Radovan Hrib  2   4
Affiliations
Review

Cannabidiol and the possibilities of its use in veterinary medicine of dogs and horses: A brief review

Leos Landa et al. Vet Med (Praha). .

Abstract

In connection with the use of cannabinoids for therapeutic purposes in human medicine, there is increased attention for their use in veterinary medicine, particularly by the owners of companion animals and horses. Therefore, veterinarians are expected to face this interest and have the corresponding knowledge on these substances. Presently, it is not possible to use medical marijuana (in terms of the dried cannabis flowers) for veterinary purposes in many countries, but there is increasing evidence that isolated cannabinoids also have beneficial effects (namely cannabidiol - CBD). Thus, this review summarises the possible therapeutic implications of CBD within the scope of evidence-based medicine, particularly in dogs and horses in association with the treatment of pain, epilepsy and anxiety in order to provide veterinarians with a concise overview of scientific findings in this field.

Keywords: cannabidiol; cannabinoids; dogs; horses; pain treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants (Basel). 2019 Dec 25;9(1):21. - PMC - PubMed
    1. Bartner LR, McGrath S, Rao S, Hyatt LK, Wittenburg LA. Pharmacokinetics of cannabidiol administered by 3 delivery methods at 2 different dosages to healthy dogs. Can J Vet Res. 2018 Jul;82(3):178-83. - PMC - PubMed
    1. Brioschi FA, Di Cesare F, Gioeni D, Rabbogliatti V, Ferrari F, D’Urso ES, Amari M, Ravasio G. Oral transmucosal cannabidiol oil formulation as part of a multimodal analgesic regimen: Effects on pain relief and quality of life improvement in dogs affected by spontaneous osteoarthritis. Animals (Basel). 2020 Aug 26;10(9):1505. - PMC - PubMed
    1. Chiocchetti R, Rinnovati R, Tagliavia C, Stanzani A, Galiazzo G, Giancola F, De Silva M, Capodanno Y, Spadari A. Localisation of cannabinoid and cannabinoid-related receptors in the equine dorsal root ganglia. Equine Vet J. 2021 May;53(3):549-57. - PubMed
    1. Collins A, Porr S, Davis A. Pharmacokinetics of a single feeding of pelleted cannabidiol in horses. ORCA Travel & Research Grants [Internet]. 2019 Aug 1. [cited 2021 May 30]. Available from: https://digitalcommons.murraystate.edu/orcagrants/74.

LinkOut - more resources